At the time of writing, Health Catalyst Inc [HCAT] stock is trading at $3.90, up 6.56%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HCAT shares have gain 5.41% over the last week, with a monthly amount drifted -12.56%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on April 09, 2025, when Evercore ISI downgraded its rating to a In-line. Previously, KeyBanc Capital Markets upgraded its rating to Overweight on January 08, 2025, and kept the price target unchanged to $9. On April 10, 2024, downgrade downgraded it’s rating to Sector Weight. Evercore ISI upgraded its rating to a Outperform but stick to its price target of $11 on January 03, 2024. Barclays initiated its recommendation with a Overweight and recommended $14 as its price target on January 03, 2024. JP Morgan upgraded its rating to Overweight for this stock on December 13, 2023, and downed its price target to $11. In a note dated November 13, 2023, Piper Sandler upgraded an Overweight rating on this stock and revised its target price from $12 to $11.
For the past year, the stock price of Health Catalyst Inc fluctuated between $3.56 and $9.24. Currently, Wall Street analysts expect the stock to reach $5.67 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $3.90 at the most recent close of the market. An investor can expect a potential return of 45.38% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
According to Health Catalyst Inc [NASDAQ:HCAT], the company’s sales were 306.58M for trailing twelve months, which represents an 6.02% jump. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.23%, and Net Profit Margin reading is -0.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.19 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.78 points at the first support level, and at 3.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.04, and for the 2nd resistance point, it is at 4.19.
Ratios To Look Out For
It is important to note that Health Catalyst Inc [NASDAQ:HCAT] has a current ratio of 1.42. Further, the Quick Ratio stands at 1.42, while the Cash Ratio is 0.77. Considering the valuation of this stock, the price to sales ratio is 0.84, the price to book ratio is 0.68.
Transactions by insiders
Recent insider trading involved LeSueur Daniel, Chief Operating Officer, that happened on Apr 03 ’25 when 5209.0 shares were sold. Officer, DANIEL LESUEUR completed a deal on Apr 03 ’25 to buy 10418.0 shares. Meanwhile, General Counsel Landry Benjamin sold 13827.0 shares on Mar 06 ’25.
